 Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Using methotrexate to treat rheumatoid arthritis can reduce the risk of cardiovascular disease

Ann Rheum Dis: Using methotrexate to treat rheumatoid arthritis can reduce the risk of cardiovascular disease

 Last Update: 2021-11-11
 Source: Internet
 Author: User

Tags

methotrexate class

beaker use

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Rheumatoid arthritis (RA) is a common type of autoimmune disease.

The study used a multicenter, prospective cohort of RA veterans to identify incidental CVD events (coronary artery disease (CAD), stroke, heart failure (HF) hospitalization, CVD death) in the cohort

Among 2044 RA patients (90% male, average age 63.

The use of MTX was associated with a 24% reduction in the risk of compound CVD events (HR 0.

Figure Forest diagram of the impact of methotrexate on CVD events

It can be seen that the use of MTX therapy in RA patients is associated with a reduction in the risk of CVD events, especially the hospitalization rate for heart failure

The use of MTX therapy in RA patients is associated with a reduced risk of CVD events, especially heart failure hospitalization rates

Original source:

Tate M Johnson.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.